ACIU Historical Income Statement
| ACIU Stock | USD 3.40 0.01 0.29% |
Historical analysis of AC Immune income statement accounts such as Selling General Administrative of 8.3 M, Total Revenue of 20 M or Cost Of Revenue of 45.8 M can show how well AC Immune performed in making a profits. Evaluating AC Immune income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of AC Immune's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining AC Immune latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AC Immune is a good buy for the upcoming year.
ACIU |
About ACIU Income Statement Analysis
AC Immune Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to AC Immune shareholders. The income statement also shows ACIU investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
AC Immune Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts AC Immune generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Cost Of Revenue
Cost of Revenue is found on AC Immune income statement and represents the costs associated with goods and services AC Immune provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from AC Immune's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into AC Immune current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AC Immune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.At this time, AC Immune's Total Revenue is comparatively stable compared to the past year. Interest Income is likely to gain to about 1.2 M in 2024, despite the fact that Gross Profit is likely to grow to (37.8 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 79.0M | 74.8M | 13.8M | 13.1M | Cost Of Revenue | 62.3M | 60.3M | 54.6M | 45.8M |
AC Immune income statement Correlations
Click cells to compare fundamentals
AC Immune Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AC Immune income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 1.9M | 184K | 581K | 355K | 176K | 167.2K | |
| Selling General Administrative | 9.4M | 11.1M | 10.9M | 15.8M | 10.6M | 8.3M | |
| Total Revenue | 111.0M | 15.4M | 944K | 3.9M | 14.8M | 20.0M | |
| Gross Profit | 60.6M | (44.1M) | (62.3M) | (56.4M) | (39.8M) | (37.8M) | |
| Operating Income | 44.5M | (61.3M) | (79.0M) | (70.8M) | (53.6M) | (50.9M) | |
| Net Income From Continuing Ops | 45.4M | (61.9M) | (73.0M) | (70.8M) | (54.2M) | (51.5M) | |
| Ebit | 44.5M | (63.2M) | (79.0M) | (71.4M) | (54.0M) | (51.3M) | |
| Cost Of Revenue | 50.4M | 59.5M | 62.3M | 60.3M | 54.6M | 45.8M | |
| Total Operating Expenses | 66.5M | 76.7M | 79.0M | 74.8M | 13.8M | 13.1M | |
| Income Before Tax | 45.4M | (61.9M) | (73.0M) | (70.7M) | (54.2M) | (51.5M) | |
| Total Other Income Expense Net | 906K | (661K) | 6.0M | 107K | (599K) | (569.1K) | |
| Net Income Applicable To Common Shares | 45.4M | (61.9M) | (73.0M) | (70.8M) | (63.7M) | (60.5M) | |
| Net Income | 45.4M | (62.1M) | (73.0M) | (70.8M) | (54.2M) | (51.5M) | |
| Income Tax Expense | 1.9M | 184K | 3K | 13K | 10K | 9.5K | |
| Depreciation And Amortization | 2.0M | 2.0M | 1.9M | 2.4M | 2.2M | 1.4M | |
| Other Operating Expenses | 66.5M | 76.7M | 79.0M | 74.8M | 68.4M | 59.2M | |
| Research Development | 50.4M | 59.5M | 62.3M | 60.3M | 54.6M | 46.5M | |
| Ebitda | 46.5M | (61.3M) | (77.1M) | (69.1M) | (51.8M) | (49.2M) | |
| Interest Income | 304K | 78K | 6.5M | 69K | 1.0M | 1.2M | |
| Net Interest Income | (1.6M) | (106K) | 5.9M | (286K) | 868K | 1.1M | |
| Reconciled Depreciation | 1.7M | 2.0M | 2.4M | 2.4M | 2.2M | 1.9M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ACIU Stock Analysis
When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.